Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies[1] Up to 80% of patients may need multiple medications to help them reach blood ...

EAST HANOVER, N.J., Dec. 3 /PRNewswire/ -- Diovan(R) (valsartan), an angiotensin receptor blocker or ARB, has been approved following a priority review by the U.S. Food and Drug Administration (FDA) ...

A common heart medication may contain a cancer-causing chemical, the FDA said. The U.S. Food and Drug Administration (FDA) is expanding a recall of a common heart medication because it may contain a ...

WASHINGTON Diovan was recently approved for treating pediatric hypertension in 6 to 16 year old patients. The approval was a for a supplemental new drug application, approved by the Division of ...

Why exactly a generic version of Novartis' blood-pressure drug Diovan has yet to hit the market is a bit of a mystery, but one thing is clear: The company is ...

NEW DELHI—Ranbaxy Laboratories Ltd. won approval Thursday to produce a generic version of Novartis AG's blockbuster, blood-pressure drug Diovan, improving the Indian company's prospects after years of ...

JERUSALEM The Food and Drug Administration has granted tentative approval for Teva Pharmaceutical Industries’ generic version of Novartis’ Diovan, Teva announced June 12. Diovan, known generically as ...

WASHINGTON/MUMBAI, June 27 (Reuters) - India's Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure ...

Ranbaxy Laboratories had the 6-month exclusive right to produce a generic of Novartis' ($NVS) blockbuster hypertension fighter Diovan. But the patent loss came and ...

Generic Diovan is coming. The Wall Street Journal reports that generics drugmaker Ranbaxy has scored an FDA approval to manufacture an off-brand version of the blood pressure medication. The drug will ...